Heart failure revascularisatio

Medical Research Council (MRC) (UK)0 个研究点目标入组 800 人开始时间: 2000年10月18日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Heart failure (in the investigators' opinion) with left ventricular systolic dysfunction (ejection fraction less than 35%) requiring chronic diuretic therapy
•2. Coronary disease as the cause of heart failure as evidenced by a history of previous myocardial infarction, previous revascularisation or previous angiography
•3. Stress-induced myocardial ischaemia or evidence of myocardial hibernation/stunning affecting five or more left ventricular segments in a 16-segment model. The core laboratories will make the decision about whether the test identifies a sufficient volume of affected myocardium

•1. Patients who are not candidates for Coronary Artery Bypass Graft (CABG) because of frailty or serious co-morbidity (eg:- severe lung disease, metastatic carcinoma)
•2. Unstable angina, myocardial infarction or stroke within the preceding two months
•3. Inability to give written informed consent
•4. Unwilling to consent to being contacted directly by staff at the data centre or unwilling to allow their hospital notes to be copied and sent to the data centre
•5. Patients being considered for revascularisation for the relief of chest pain (angina) or valve surgery
•6. Patients involved in another randomised controlled trial

发起方

Medical Research Council (MRC) (UK)